MedTrace Logo

Tissue Engineering Conjunctiva for the Treatment of Pterygium and Atretoblepharia

NCT02911532 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-08-16

No results posted yet for this study

Summary

The purpose of this study is to determine whether tissue engineering conjunctiva is effective in the treatment of pterygium and atretoblepharia.

Conditions

  • Pterygium

Interventions

PROCEDURE

Tissue engineering conjunctiva transplantation

During the operation,transplant the tissue engineering conjunctiva to the conjunctiva loss position

Sponsors & Collaborators

  • Shandong Eye Hospital

    lead OTHER

Principal Investigators

  • Weiyun Shi, sponsor · director of shandong eye hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2017-10-01
Completion
2018-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02911532 on ClinicalTrials.gov